Delivery Order SPE2DB22D1103-SPE2DB25FH0B3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,535.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 22, 2025, with completion targeted for August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.14 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 17, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by July 18, 2025, with the product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,377.02 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml dose). This firm fixed price, non-set-aside contract is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,167.48 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on August 13, 2025. This competitively awarded, firm fixed-price contract represents a single delivery transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency awarded a delivery order valued at $14,757.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes treatment medication commonly used within military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 13, 2025, valued at $1,201.20 for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used to...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH0B3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 14, 2025. This firm fixed-price delivery order, issued under a non-competitive, non-set-aside procurement, represents a single fulfillment against AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania, with a completion deadline of August 15, 2025. Trulicity is a branded diabetes medication commonly used within military and federal healthcare systems to support chronic disease management for service members and beneficiaries. This delivery order is a child contract executed under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical supply vehicle. AmerisourceBergen's status as a major pharmaceutical distributor and critical federal medical procurement vendor is evidenced by its consistent receipt of competitively awarded contracts across multiple therapeutic domains. The underlying IDC enables the company to supply a broad range of brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/14/25 |